Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo formula decreases the disease activity and the level of serum thymus and activation-regulated chemokine (TARC) in patients with atopic dermatitis
-
- MAKINO Teruhiko
- Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
-
- FURUICHI Megumi
- Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
-
- WATANABE Hirokazu
- Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
-
- YOSHIHISA Yoko
- Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
-
- SHIMIZU Tadamichi
- Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
Bibliographic Information
- Other Title
-
- Short communication: Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo formula decreases the disease activity and the level of serum thymus and activation-regulated chemokine (TARC) in patients with atopic dermatitis
Search this article
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disorder with pruritic and eczematous lesions. AD is characterized by the predominant infiltration of Th2-type cells in the acute phase of skin lesions. Thymus and activation-regulated chemokine (TARC), a member of the CC chemokine superfamily was identified as a selective chemoattractant for Th2-type cells. The serum TARC level is significantly increased in patients with AD and is correlated with the severity of AD. Keishibukuryogan (KBG) is a Kampo formula composed of five kind of crude drugs and has been administered to patients with blood stagnation in Japan. This study investigated the effect of KBG on disease activity and TARC production in AD patients. AD patients were administered KBG for 4 to 6 weeks in addition to their prescribed medications. The SCORAD index and VAS score were decreased by the administration of KBG. The serum TARC level of the AD patients was much higher than that of normal controls. This elevated serum TARC level was significantly decreased by administration of KBG. These results suggest that KBG may improve AD by the inhibitory effect on Th2-type chemokine production.
Journal
-
- Journal of Traditional Medicines
-
Journal of Traditional Medicines 24 (5), 173-175, 2007
Medical and Pharmaceutical Society for WAKAN-YAKU
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205233894656
-
- NII Article ID
- 130004495502
- 110006437775
-
- NII Book ID
- AA12035198
-
- ISSN
- 18813747
- 18801447
-
- HANDLE
- 10110/1530
-
- NDL BIB ID
- 9263732
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- IRDB
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed